| Today’s Big NewsMar 12, 2025 |
|
Thursday, April 3, 2025 | 11am ET / 8am PT Join us for an insightful webinar on the latest advancements in cell and gene therapy, focusing on the innovative Cas9-CLIPT (Cleaved, Linearized with Protein Template) technology. Learn more about this groundbreaking technology designed to improve the efficiency of genome editing. Register now.
|
|
| By Nick Paul Taylor Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipeline. The outlay, plus up to $3.6 billion in milestones, has secured Roche the right to codevelop and co-commercialize Zealand Pharma’s long-acting amylin analog petrelintide. |
|
|
|
By Kevin Dunleavy In his third year as the CEO of Johnson & Johnson, Joaquin Duato received an overall compensation package of $24.3 million. It was a 14% decrease from his $28.4 million figure in 2023, when he was the highest-paid Big Pharma chief executive. |
By Conor Hale Insilico's series E round was led by Hong Kong-based firm Value Partners, and joined by Insilico’s previous investors plus unnamed first-time backers. |
By James Waldron Japan's Ono Pharmaceutical is paying $280 million upfront to acquire Ionis Pharmaceutical’s phase 2-stage antisense oligonucleotide for a rare type of blood cancer. |
By Nick Paul Taylor GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its plans to create a six-month regimen are shaping up. |
By Andrea Park Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, according to the latest edition of Trinity Life Sciences’ annual Drug Index. The report looked at several factors to rank the industry's top launches from 2021. |
By Conor Hale Dubbed Monarch Quest, the Nvidia-backed AI program can interface with GE HealthCare’s OEC 3D C-arm imaging system for live cone-beam CT navigation. |
By Zoey Becker The facility will be used to develop and produce Entos' Fusogenix proteolipid vehicles (PLVs), which attracted Eli Lilly's interest for a partnership. The governments of Canada and Alberta are chipping in to help fund the site. |
Fierce podcastsDon’t miss an episode |
| This week on "The Top Line," we dig into several of the biggest private funding rounds in biotech last year and discuss the shifting VC landscape. |
|
|---|
|
|
|
Wednesday, April 9, 2025 | 10am ET / 7am PTLearn the key steps for successfully entering Japan’s pharmaceutical market. This webinar covers regulatory requirements, compliance strategies, supply chain best practices, and common challenges. Gain expert insights to navigate this high-potential market with confidence. Don’t miss out—register now to secure your spot!
|
|
| WhitepaperRead about four trends that will shape the innovations, therapies, & market landscape in oncology during 2025 & beyond. Presented by Blue Matter, strategic consultants in the life sciences |
| WhitepaperDiscover how to revolutionize your vaccine trials with Avacare's latest white paper. Gain exclusive access to innovative, data-driven recruitment strategies that ensure diverse, efficient, and high-quality vaccine trials. Sponsored by: Avacare Clinical Research Network |
| WhitepaperDevelop your CAR molecule faster Sponsored by: Cell Signaling Technology |
| |
|
